Y. Erhan et al., A clinicopathologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis, BREAST, 9(1), 2000, pp. 52-56
Idiopathic granulomatous mastitis (IGM) is a rare chronic inflammatory lesi
on of the breast clinically simulating carcinoma. The purpose of this repor
t is to review the clinicopathological features of this clinical entity in
a series of 18 cases diagnosed in our institute. The notes of patients and
the slides of the biopsy specimens of 18 cases with IGM were reviewed. Spec
ial stains for organisms and immunohistochemistry for T and B markers using
the primary antibody was done. The diagnosis of IGM was made according to
the criteria of Kessler and Wolloch. All but two patients were of reproduct
ive age and all were parous. The main clinical finding was a unilateral, fi
rm, discrete mass. All patients underwent excisional biopsy and recurrence
was seen in three patients. In two of these patients who had recurrences, t
he prolactin level was high and reexcision combined with antiprolactinemic
therapy was performed. The third patient was treated by reexcision and oral
prednisone. There was granulomatous inflammation, centered mainly on breas
t lobules in all patients. T cell domination was observed. Exclusion of the
other causes of a granulomatous lesion is necessary to make the diagnosis
of IGM. The treatment of choice is unclear. Because of the clinical concern
of malignancy, fine-needle aspiration cytology or core biopsy can be usefu
l in some cases. To differentiate it from other granulomatous lesions, inci
sional biopsy or surgical excision of the lesion is necessary. In patients
with delayed wound healing or recurrence after excisional biopsy, or those
patients who have had an incisional biopsy only, if prolactin level is norm
al, reexcision and oral prednisone usage may be curative. In patients with
a high prolactin level who have recurrence, medical treatment to control pr
olactin level may be useful in the management of these women. (C) 2000 Harc
ourt Publishers Ltd.